Summary
Pharmaceuticals in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Chinese pharmaceuticals market had total revenues of $132.9m in 2018, representing a compound annual growth rate (CAGR) of 8.2% between 2014 and 2018.
- The performance of the market is forecast to accelerate, with an anticipated CAGR of 12% for the five-year period 2018-2023, which is expected to drive the market to a value of $234.7m by the end of 2023.
- Increasing regulatory stringency and transparency are designed to bolster quality within market and are strong grounds for future optimism.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in China
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in China
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the China pharmaceuticals market with five year forecasts
Reasons to buy
- What was the size of the China pharmaceuticals market by value in 2018?
- What will be the size of the China pharmaceuticals market in 2023?
- What factors are affecting the strength of competition in the China pharmaceuticals market?
- How has the market performed over the last five years?
- How large is China’s pharmaceuticals market in relation to its regional counterparts?
'
Table of Contents
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Guangzhou Pharmaceutical Holdings Ltd
Shanghai Pharmaceuticals
Yangtze River Pharmaceutical Group
Yunnan Baiyao Group Co Ltd
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
List of Tables
Table 1: China pharmaceuticals market value: $ billion, 2014-18
Table 2: China pharmaceuticals market geography segmentation: $ billion, 2018
Table 3: China pharmaceuticals market share: % share, by value, 2018
Table 4: China pharmaceuticals market value forecast: $ billion, 2018-23
Table 5: Guangzhou Pharmaceutical Holdings Ltd: key facts
Table 6: Shanghai Pharmaceuticals: key facts
Table 7: Shanghai Pharmaceuticals: key financials ($)
Table 8: Shanghai Pharmaceuticals: key financials (CNY)
Table 9: Shanghai Pharmaceuticals: key financial ratios
Table 10: Yangtze River Pharmaceutical Group: key facts
Table 11: Yunnan Baiyao Group Co Ltd: key facts
Table 12: Yunnan Baiyao Group Co Ltd: key financials ($)
Table 13: Yunnan Baiyao Group Co Ltd: key financials (CNY)
Table 14: Yunnan Baiyao Group Co Ltd: key financial ratios
Table 15: China size of population (million), 2014-18
Table 16: China gdp (constant 2005 prices, $ billion), 2014-18
Table 17: China gdp (current prices, $ billion), 2014-18
Table 18: China inflation, 2014-18
Table 19: China consumer price index (absolute), 2014-18
Table 20: China exchange rate, 2014-18
List of Figures
Figure 1: China pharmaceuticals market value: $ billion, 2014-18
Figure 2: China pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 3: China pharmaceuticals market share: % share, by value, 2018
Figure 4: China pharmaceuticals market value forecast: $ billion, 2018-23
Figure 5: Forces driving competition in the pharmaceuticals market in China, 2018
Figure 6: Drivers of buyer power in the pharmaceuticals market in China, 2018
Figure 7: Drivers of supplier power in the pharmaceuticals market in China, 2018
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2018
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2018
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in China, 2018
Figure 11: Shanghai Pharmaceuticals: revenues & profitability
Figure 12: Shanghai Pharmaceuticals: assets & liabilities
Figure 13: Yunnan Baiyao Group Co Ltd: revenues & profitability
Figure 14: Yunnan Baiyao Group Co Ltd: assets & liabilities
